Diagnose Diabetic Neuropathy with Tear Biomarker
Non-invasive Biomarker for Diabetic Neuropathy
Tags: University of Melbourne, Australia, Healthcare & Lifesciences
A tear biomarker offers a non-invasive diagnostic for diabetic neuropathy, bypassing current invasive methods. It enables early diagnosis and monitors treatment efficacy, crucial for diabetic corneal disease prevalent in over half of diabetes patients. Current diagnostics are invasive or require costly equipment and expertise, limiting accessibility. This innovation promises a simple kit for widespread use by optometrists and GPs, even in remote areas. It represents a significant advance in managing diabetes-related complications.
IP Type or Form Factor: Patent Pending; Discovery & Research
TRL: 3 - proof of concept with needs validated
Industry or Tech Area: Diagnostics & Screening; Biotechnology
